Oncocyte Corporation - Common Stock (OCX)

Oncocyte Corporation is a biotechnology company focused on developing innovative diagnostic solutions for cancer patients

The company specializes in the discovery and commercialization of proprietary tests that aid in the diagnosis, prognosis, and treatment selection for various types of cancer. By employing advanced genomics and other cutting-edge technologies, Oncocyte aims to provide healthcare professionals with valuable insights to improve patient outcomes and streamline the decision-making process in oncology. Through its research and development efforts, the company seeks to enhance precision medicine and support personalized treatment strategies in the fight against cancer.